Scopic: When your problem won’t fit in a software box

Steve Gardner had a problem with teeth. More precisely, he had a problem with the software meant to model them. His company, OrthoSelect, wanted to help orthodontists plan where brackets should sit on a patient’s teeth. A local development company had produced disappointing results. Freelancers followed. In Scopic’s published account, the work remained unreliable and expensive. There was a promising product, a self-funded business and a development bill consuming too much of its income. Finding another programmer was only part of the answer.

The teeth were the easy part

Gardner eventually chose Scopic. The company’s 2020 case study describes a dedicated development team adding bracket adjustment, superimposition and treatment simulations. That is a more revealing list than “digital transformation.” An orthodontist needs to manipulate a model, compare positions and see what a proposed intervention might do. Each useful feature begins with understanding the practitioner’s task.

Scopic’s newer account traces OrthoSelect’s DIBS AI from heuristics into deep learning, with contributions from Scopic and other developers. Its work includes teeth segmentation, correcting scan imperfections and automating parts of case preparation. The product combines software with 3D-printed bracket-transfer appliances. A digital decision has a physical destination: someone’s mouth.

This is where Scopic’s business becomes legible. It is a development company for organizations whose requirements are particular enough to justify custom work. Web, mobile and desktop applications are its materials; healthcare, finance, manufacturing and media supply the problems. The customer buys an engineering engagement, sometimes an extension of an existing team. There is no universal Scopic application that an orthodontist, a trader and a radiologist all subscribe to.

A founder becomes the bottleneck

Tim Burr founded Scopic in 2006 after working in software at companies including IBM and Teradyne. The early focus was 3D and desktop development. Web and mobile work followed. His 2017 retrospective describes a company that accumulated programmers faster than management capacity. By 2012, growing pains had arrived.

“The company was very ‘lean and mean’, but it was not scalable.”

Tim Burr / 2017 retrospective

Scopic gradually added functional managers and systems for accounting, time approval and performance reviews. The lesson is pleasantly unromantic: even a virtual business needs administration. A founder who mediates every department becomes a queue. Giving decisions an owner lets the organization keep moving without making every question a personal summons.

Today, Scopic describes a fully remote operation. Its anniversary account reports contributors from more than 90 countries across twenty years. That number measures historical representation, rather than the geography of today’s payroll. The distinction matters. A company can have a large international history while each customer still depends on the competence of a small, assigned team.

The doctor still gets the last word

Mediphany gives the story a second useful test. Its founders wanted to make medical imaging understandable through video explanations. A radiologist’s interpretation is valuable; turning that interpretation into accessible material requires another set of skills. Scopic helped build the platform, including frontend and backend development, testing and infrastructure.

The AI addition tackles report preparation. Speech becomes text; a model maps the text into a suitable template; the resulting report is color-coded so a radiologist can review and approve changes. The system sits inside Mediphany’s Recorder Desktop application. It improves an existing working environment rather than requiring the doctor to assemble a separate collection of tools.

Scopic’s case study reports 85% transcription accuracy and 85% mapping accuracy. Those figures concern speech and report fields. They are not measures of diagnostic accuracy. This is precisely why the review step deserves attention: an imperfect machine output can be useful when the product makes checking it part of the job.

The project’s technical ingredients include Deepgram’s medical speech model, OpenAI technology and an AWS deployment. Buying access to those services does not, by itself, produce a reporting system. Someone still has to connect the components, handle templates and make the output usable. Scopic’s market sits in that space between available technology and a working product.

What the hourly rate leaves out

Scopic primarily bills development by the hour. For managed projects, its website describes an estimate using working hours and a blended team rate. Staff augmentation rates depend on the individual’s seniority and technical stack. Design, quality assurance, project management and cloud operations can all be part of the work. A buyer comparing only developer rates risks pricing one ingredient instead of the meal.

Those numbers are bearings for a buying conversation. Scopic’s FAQ says proposals include scope, milestones, estimated timing and a cost breakdown; scope changes require discussion of their cost implications. A client needs enough specificity for the team to estimate the work, and enough discipline to notice when the work changes.

Mediphany’s CEO, Josh Polster, told Clutch that early expectations around deadlines and costs needed correction, which Scopic addressed. His advice to prospective customers was to be precise about requirements. That is a useful counterweight to the company’s success stories. A capable supplier still needs a legible brief.

The alternatives are familiar: an internal team, independent developers, another agency or an existing software product. Scopic’s case for consideration rests on its domain-specific portfolio and the ability to provide several disciplines together. For a routine requirement already covered by a suitable product, commissioning custom software adds a project to manage. For a demanding 3D or medical workflow, a generalist’s lower rate may offer little guidance about the final result.

After the code, the customers

A functioning application does not arrange its own audience. Scopic added digital marketing in 2017 and established Scopic Studios in 2024. The agency offers search optimization, paid campaigns, email and social media. This broadens the commercial relationship from making something usable to helping the right people find it.

Mertech, an application-modernization business, illustrates the marketing work. Its Scopic Studios portfolio entry describes SEO aimed at companies using legacy systems, plus LinkedIn and email campaigns. The audience has a particular problem, just as an orthodontist does. A persuasive message has to understand the work before it can sell the solution.

The wider development portfolio includes ShadeWave’s dental color-matching application and MD Ally’s telehealth support for non-critical patients in the 911 ecosystem. These examples show why “IT services” is such an inadequate description. The difficult part is often the translation between a professional’s knowledge and the interface another person must use.

Borrow the prototype, not the mythology

One of Mediphany’s most transferable practices happens before development. In its 2025 interview, the company describes using Figma to test a new module. A clickable prototype lets people inspect the proposed experience, give feedback and refine the idea before paying to implement it. The method is available to a small business as well as a healthcare startup.

Another lesson is to assign review where error matters. Mediphany’s reporting workflow makes approval explicit. OrthoSelect’s AI work required iterative training. These projects depend on customers who can explain their domain and evaluate the results. Without that participation, a distributed team can faithfully build the wrong thing, or automate an output nobody is equipped to check.

Scopic’s appeal is clearest when a company has a specific problem, needs more than one technical discipline and can remain involved in decisions. The buyer should ask who will own delivery, how changes will be priced and what evidence will show that the software works. Gardner’s teeth offer a memorable place to start: choose the team by the problem it understands, then make that understanding visible in the product.